Journal of Ethnopharmacology 103 (2006) 484–490
Ethnopharmacological communication
Hepatoprotective effects of rubiadin, a major constituent
of Rubia cordifolia Linn.
Guntupalli M. Mohana Rao
a,∗
, Chandana V. Rao
a
,
Palpu Pushpangadan
a
, Annie Shirwaikar
b
a
Pharmacognosy and Ethnopharmacology Division, National Botanical Research Institute, Lucknow 226 001, Uttarpradesh, India
b
Department of Pharmacognosy, College of Pharmaceutical Sciences, Manipal 576 119, Karnataka, India
Received 16 April 2005; received in revised form 4 August 2005; accepted 16 August 2005
Available online 5 October 2005
Abstract
The hepatoprotective effects of rubiadin, a major constituent isolated from Rubia cordifolia Linn., were evaluated against carbon tetrachloride
(CCl
4
)-induced hepatic damage in rats. Rubiadin at a dose of 50, 100 and 200 mg/kg was administered orally once daily for 14 days. The substantially
elevated serum enzymatic activities of serum glutamic oxaloacetic transaminase (SGOT), serum glutamate pyruvate transaminase (SGPT), serum
alkaline phosphatase (SALP) and -glutmyltransferase (-GT) due to carbontetrachloride treatment were dose dependently restored towards
normalization. Meanwhile, the decreased activities of glutathione S-transferase and glutathione ruductase were also restored towards normalization.
In addition, rubiadin also significantly prevented the elevation of hepatic melondialdehyde formation and depletion of reduced glutathione content
in the liver of CCl
4
intoxicated rats in a dose dependent manner. Silymarin used as standard reference also exhibited significant hepatopretective
activity on post treatment against carbon tetrachloride induced hepatotoxicity in rats. The biochemical observations were supplemented with
histopathological examination of rat liver sections. The results of this study strongly indicate that rubiadin has a potent hepatoprotective action
against carbon tetrachloride induced hepatic damage in rats.
© 2005 Published by Elsevier Ireland Ltd.
Keywords: Rubia cordifolia; Rubiadin; Carbon tetrachloride; Hepatoprotective effect; Silymarin; Histopathology
1. Introduction
Liver regulates various important metabolic functions. Hep-
atic damage is associated with distortion of these metabolic
functions (Wolf, 1999). Liver disease is still a world wide health
problem. Unfortunately, conventional or synthetic drugs used in
the treatment of liver diseases are inadequate and sometimes can
have serious side effects. This is one of the reasons for many
people in the world over including those in developed coun-
tries turning complimentary and alternative medicine (CAM).
Many traditional remedies employ herbal drugs for the treat-
ment of liver ailments (Dhuley and Naik, 1997; Venkateswaran
et al., 1997; Latha et al., 1999; Mitra et al., 2000). Rubiadin, 1,3-
dihydroxy-2-methyl anthraquinone has been isolated from the
50% aqueous EtOH extract of roots of Rubia cordifolia Linn.
∗
Corresponding author. Fax: +91 522 2205836.
E-mail address: mmraos@rediffmail.com (G.M.M. Rao).
(Rubiaceae). Rubia cordifolia is an important medicinal plant
which is used for treatment of various ailments in Ayurvedic sys-
tem of medicine (George, 1967; Pandey and Chunnekar, 1967;
Sertoli et al., 1994; Adwankar et al., 1980; Singh et al., 1983;
Tripathi et al., 1993; Pandey et al., 1994). Rubiadin, isolated
from the roots of Rubia cordifolia was found to have potent
antioxidant property (Tripathi et al., 1993), In addition, rubiadin
also have been found to inhibit lipid peroxidation (Tripathi and
Sharma, 1998) and the plant Rubia cordifolia have been reported
for anti-inflammatory (Antarkar et al., 1983), immunomodula-
tory (Joharapurkar et al., 2003), anticonvulsant and anxiolytic
(Kasture et al., 2000) and anti-tumor activities (Manohar et al.,
1982). In the ethnobotanical claims, it is mentioned as, the roots
are used for the treatment of jaundice by the folk tribes of west
Bengal and Uttaranchal (Jain, 1991), but to the best of our knowl-
edge there is no scientific report on the hepatoprotective activity
of Rubia cordifolia. Therefore, to justify the traditional claims
we have assessed the hepatoprotective effects of rubiadin using
CCl
4
-intoxicated rats as experimental model.
0378-8741/$ – see front matter © 2005 Published by Elsevier Ireland Ltd.
doi:10.1016/j.jep.2005.08.073